semaglutide versions FDA warns about compounded of popular weight loss drugs Novo Nordisk prepares new cheaper

Only use compounded drugs if FDA-approved medicines are unavailable

Some patients prefer morning administration to allow any mild nausea to resolve during the day, while others may prefer evening injection if they experience fatigue or other symptoms following administration

Patients with a history of chronic pancreatitis, pancreatic cancer, or other significant pancreatic disorders may not be suitable candidates for this therapy

The Semaglutide Oral Protocol from PlexusDx is a compounded GLP-1 agonist prescribed by licensed providers

They are also forbidden from "misleading" advertising and using any Novo Nordisk trademarks or logos in their products